Cano Health, Inc.: Nasdaq/NYSE listing notice — NYSE suspends trading and commences delisting of Cano Health after Chapter 11 filing on Feb 4

Cano Health, Inc.

NYSE suspended trading in Cano Health (CANO) on Feb 5 after Chapter 11 filing on Feb 4.
The NYSE will apply to the SEC to delist the stock; company does not intend to appeal.
Common stock expected to trade on OTC Markets under symbol CANOQ.
Cano Health warns that holders could experience a complete loss depending on bankruptcy outcome.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Cano Health, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

Exchange: nyse
Notice: delisting notice
Rules: 802.01D

Exact text from the filing

February 5, 2024, the New York Stock Exchange (the “ NYSE ”) notified (the “ Notice ”) Cano Health, Inc. (the “ Company ”) that the NYSE had determined to (a) commence proceedings to delist the Company’s Class A common stock, par value $0.01 per share (“ Common Stock ”) and (b) immediately suspend trading in the Company’s Common Stock pursuant to Section 802.01D of the NYSE Listed Company Manual after the Company filed voluntary petitions for relief under Chapter 11 of title 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on February 4, 2024. The NYSE w

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-24-024136

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.